Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Disease, Lung Neoplasms, Pneumonia

Mesothelioma, Malignant

Carcinoma, Non-Small-Cell Lung

Disease, Lung Neoplasms, Motor Activity

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Kidney Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Lung Diseases, Lung Neoplasms

Small Cell Lung Carcinoma

Lung Diseases, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm, Residual

Alk-positive Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Melanoma, Leukemia, Myeloid, Acute

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

SCLC,Extensive Stage

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms, Postoperative Complications

Lung Neoplasms

Lung Neoplasms, Lung Diseases, Interstitial

Lung Neoplasms

Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Lung Neoplasms

Locally Advanced Non Small Cell Lung Cancer

Lung Neoplasms

Lung Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Fatigue, Lung Neoplasms

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ?

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Anosmia, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Brain Diseases, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Lung Neoplasms

Clinical Trials

SISTEMA

VICTORY 2

OMIM

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

EXHALE-CO2

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

SARCO-CTI

NSCLC SCLC

PEMBRO-K

ES-SCLC

NoSurgery

Comparison of Double Lumen Tube Location Verification Techniques in Single Lung Ventilation

PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases

Optimizing Post-Thoracotomy Pain Management: Comparing Erector Spinae vs. Paravertebral Block in Thoracotomy Patients

Organoid-guided Personalized Treatment of Pleural Effusion

A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases

FACT-L_Pred

MRDSEEKER

ALKDigPath

Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

CANSI

LUCIA

Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer

SCLC

UNICORN

The Effect of Nutritional Risk Parameters on Postoperative Pulmonary Complications in Geriatric Thoracic Surgery Cases

qUEST

EXHALE 1B

Cost-effectiveness Evaluation of Robotic Surgery in the Removal of Lung Lesions in the ATS of Milan

NSCLC

the Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy

Classification of Benign and Malignant Lung Nodules Based on CT Raw Data

SPORT

Study of CT and MR in the Lung Cancer

Sleep Apnea and Lung Cancer

Study of Prevalence of Ipsilateral Shoulder Pain in Patients After Thoracic Surgeries

TELE001

K-LUCAS

Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment

Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors

Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment

EVALUATE

Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?

HOC-LC

SITRR

The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer

Identifying Unique Scent Signature of Lung Cancer Through Body Odor

007/055/OMI

Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer

Exhaled Breath Biomarkers in Lung Cancer